Increased cutting speed of 25,000 cuts per minute 1 is designed to minimize retinal traction, 2 increase vitreous flow 1 and reduce infusion pressure...
Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 scientific data...
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026
Revenue of $1.244 Billion Revenue Grew 9% as Reported and 6% on a Constant Currency 1 Basis Compared to the First Quarter...
Barchart Research What to Expect from BLCO Earnings BLCO Generated April 28, 2026 Current Price $15.72 EPS Estimate $$0.06 Consensus Rating Hold Average Move 4.21% Bausch & Lomb Reports Tomorrow With Analysts...
Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For
Drawing on more than two decades of scientific evidence, a comprehensive review synthesizes more than 20 human studies highlighting the potential role of certain B vitamins in supporting eye health to...
The Broader Perspective framework sets direction for long-term environmental and social impact